Inventiva (IVEVF) Share-based Compensation (2019 - 2022)
Inventiva (IVEVF) posted Share-based Compensation of $1.7 million for Q4 2022, up 166.66% on a QoQ basis from -$2.5 million in Q3 2022, and up 61.2% year-over-year from $1.0 million in Q4 2021.
Analysis
Inventiva (IVEVF) Share-based Compensation (2019 - 2022) Analysis & Trends
Inventiva has reported Share-based Compensation for 4 years, with the latest figure at $1.7 million in Q4 2022.
- On a quarterly basis, Share-based Compensation rose 61.2% year-over-year to $1.7 million in Q4 2022; TTM through Dec 2022 was $1.3 million, a 66.2% decrease from a year earlier, with the FY2025 full-year figure at $31.2 million, up 714.53% from the prior year.
- Share-based Compensation was $1.7 million for Q4 2022 at Inventiva, up from -$2.5 million in the prior quarter.
- The five-year high for Share-based Compensation was $1.7 million in Q4 2022, with the low at -$2.5 million in Q3 2022.
- Average Share-based Compensation over 4 years is $631676.0, with a median of $1.1 million recorded in 2021.
- The sharpest annual moves came in 2021 and 2022: Share-based Compensation plunged 92.75% in 2021, then soared 61.2% in 2022.
- Over 4 years, Share-based Compensation stood at $1.2 million in 2019, then surged by 33.84% to $1.6 million in 2020, then sank by 36.71% to $1.0 million in 2021, then jumped by 61.2% to $1.7 million in 2022.
- The last three Share-based Compensation figures came in at $1.7 million (Q4 2022), -$2.5 million (Q3 2022), and $1.0 million (Q4 2021), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.71 Bn | 625.95 Bn | 17.26 Bn | -950.00 Mn |
| 2 | AbbVie | 442.22 Bn | 435.65 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 366.92 Bn | 359.78 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 266.90 Bn | 259.21 Bn | 11.24 Bn | - |
| 5 | Pfizer | 159.20 Bn | 147.50 Bn | 10.94 Bn | 249.00 Mn |
| 6 | Sanofi | 52.44 Bn | 45.06 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 44.11 Bn | 44.11 Bn | - | 277.20 Mn |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | 67.26 Mn |
| 9 | United Therapeutics | 21.50 Bn | 18.84 Bn | 683.80 Mn | 19.00 Mn |
| 10 | Inventiva | 693.72 Mn | 693.72 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2022 | 1.68 Mn |
| Sep 22, 2022 | -2.51 Mn |
| Dec 31, 2021 | 1.04 Mn |
| Jun 30, 2021 | 1.08 Mn |
| Mar 31, 2021 | 19,299.78 |
| Dec 31, 2020 | 1.64 Mn |
| Jun 30, 2020 | 1.25 Mn |
| Mar 31, 2020 | 266,049.31 |
| Dec 31, 2019 | 1.23 Mn |